SILVERARC CAPITAL MANAGEMENT, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$542.3B
Holdings
65
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (65 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 741,972 | $39.0B | 7.20% | |
| 2 | AKROAKERO THERAPEUTICS INC | 713,811 | $38.1B | 7.02% | |
| 3 | VRNAVERONA PHARMA PLC | 358,297 | $33.9B | 6.25% | |
| 4 | URGNUROGEN PHARMA LTD | 2,022,482 | $27.7B | 5.11% | |
| 5 | RYTMRHYTHM PHARMACEUTICALS INC | 400,772 | $25.3B | 4.67% | |
| 6 | IM8NINSMED INC | 249,060 | $25.1B | 4.62% | |
| 7 | KALVKALVISTA PHARMACEUTICALS INC | 1,832,171 | $20.7B | 3.82% | |
| 8 | NBIXNEUROCRINE BIOSCIENCES INC | 162,969 | $20.5B | 3.78% | |
| 9 | —MERUS N V | 382,500 | $20.1B | 3.71% | Call |
| 10 | ETNBGBP89BIO INC | 2,037,087 | $20.0B | 3.69% | |
| 11 | ORICORIC PHARMACEUTICALS INC | 1,800,829 | $18.3B | 3.37% | |
| 12 | NUVLNUVALENT INC | 235,583 | $18.0B | 3.31% | |
| 13 | SLNOSOLENO THERAPEUTICS INC | 204,591 | $17.1B | 3.16% | |
| 14 | LVLNSPDR SERIES TRUST | 200,000 | $16.6B | 3.06% | Call |
| 15 | ASNDASCENDIS PHARMA A/S | 86,552 | $14.9B | 2.75% | |
| 16 | CGONCG ONCOLOGY INC | 541,034 | $14.1B | 2.59% | |
| 17 | VCYTVERACYTE INC | 448,495 | $12.1B | 2.24% | |
| 18 | SRRKSCHOLAR ROCK HLDG CORP | 341,010 | $12.1B | 2.23% | |
| 19 | RNAAVIDITY BIOSCIENCES INC | 410,000 | $11.6B | 2.15% | |
| 20 | PCVXVAXCYTE INC | 287,796 | $9.4B | 1.73% | |
| 21 | PFEPFIZER INC | 344,338 | $8.3B | 1.54% | |
| 22 | NUVLNUVALENT INC | 100,200 | $7.6B | 1.41% | Call |
| 23 | HLXCHELIX ACQUISITION CORP II | 613,393 | $6.5B | 1.20% | |
| 24 | GOSSGOSSAMER BIO INC | 5,146,782 | $6.3B | 1.17% | |
| 25 | MTSRMETSERA INC | 207,581 | $5.9B | 1.09% | |
| 26 | ELUTELUTIA INC | 2,761,684 | $5.5B | 1.01% | |
| 27 | CGENCOMPUGEN LTD | 3,033,879 | $5.4B | 1.00% | |
| 28 | TELATELA BIO INC | 2,779,795 | $5.4B | 0.99% | |
| 29 | ABEOABEONA THERAPEUTICS INC | 917,898 | $5.2B | 0.96% | |
| 30 | CDTXCIDARA THERAPEUTICS INC | 103,943 | $5.1B | 0.93% | |
| 31 | TCE2CELLDEX THERAPEUTICS INC NEW | 198,441 | $4.0B | 0.74% | |
| 32 | AARDAARDVARK THERAPEUTICS INC | 286,807 | $3.9B | 0.72% | |
| 33 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 82,023 | $3.9B | 0.71% | |
| 34 | SNDXSYNDAX PHARMACEUTICALS INC | 402,964 | $3.8B | 0.70% | |
| 35 | GPCRSTRUCTURE THERAPEUTICS INC | 175,636 | $3.6B | 0.67% | |
| 36 | CCOICOGENT COMMUNICATIONS HLDGS | 500,000 | $3.6B | 0.66% | Call |
| 37 | CERSCERUS CORP | 2,488,291 | $3.5B | 0.65% | |
| 38 | ERASERASCA INC | 2,569,591 | $3.3B | 0.60% | |
| 39 | CMPXCOMPASS THERAPEUTICS INC | 1,249,781 | $3.2B | 0.60% | |
| 40 | SIONSIONNA THERAPEUTICS INC | 186,015 | $3.2B | 0.60% | |
| 41 | BNTCBENITEC BIOPHARMA INC | 253,234 | $3.0B | 0.55% | |
| 42 | TRVITREVI THERAPEUTICS INC | 539,587 | $3.0B | 0.54% | |
| 43 | QUREUNIQURE NV | 202,565 | $2.8B | 0.52% | |
| 44 | HIMSHIMS & HERS HEALTH INC | 50,000 | $2.5B | 0.46% | Put |
| 45 | KNSAKINIKSA PHARMACEUTICALS INTL | 75,959 | $2.1B | 0.39% | |
| 46 | ORKAORUKA THERAPEUTICS INC | 165,389 | $1.9B | 0.34% | |
| 47 | DNTHDIANTHUS THERAPEUTICS INC | 95,806 | $1.8B | 0.33% | |
| 48 | TRMLTOURMALINE BIO INC | 109,257 | $1.7B | 0.32% | |
| 49 | MLYSMINERALYS THERAPEUTICS INC | 115,282 | $1.6B | 0.29% | |
| 50 | KODKODIAK SCIENCES INC | 401,540 | $1.5B | 0.28% | |
| 51 | CAPRCAPRICOR THERAPEUTICS INC | 144,700 | $1.4B | 0.26% | Put |
| 52 | DCTHDELCATH SYS INC | 103,026 | $1.4B | 0.26% | |
| 53 | —AKERO THERAPEUTICS INC | 25,000 | $1.3B | 0.25% | Call |
| 54 | —MERSANA THERAPEUTICS INC | 3,128,421 | $926.0M | 0.17% | |
| 55 | RADXRADIOPHARM THERANOSTICS LTD | 187,406 | $869.6M | 0.16% | |
| 56 | MODDMODULAR MED INC | 710,363 | $529.2M | 0.10% | |
| 57 | SNDXSYNDAX PHARMACEUTICALS INC | 50,000 | $468.0M | 0.09% | Call |
| 58 | PRAXPRAXIS PRECISION MEDICINES I | 10,000 | $420.5M | 0.08% | |
| 59 | GUTSFRACTYL HEALTH INC | 202,590 | $328.2M | 0.06% | |
| 60 | BDSXBIODESIX INC | 1,070,367 | $302.1M | 0.06% | |
| 61 | SGMTSAGIMET BIOSCIENCES INC | 37,539 | $286.0M | 0.05% | |
| 62 | ELVNENLIVEN THERAPEUTICS INC | 10,000 | $200.6M | 0.04% | |
| 63 | CNTACENTESSA PHARMACEUTICALS PLC | 5,000 | $65.7M | 0.01% | |
| 64 | NKTRNEKTAR THERAPEUTICS | 346 | $8.9M | 0.00% | |
| 65 | RCKTWROCKET PHARMACEUTICALS INC | 104,828 | $3.0M | 0.00% |